共 50 条
- [31] Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanomaBMC CANCER, 2018, 18Amini-Adle, M.论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, FranceKhanafer, N.论文数: 0 引用数: 0 h-index: 0机构: Claude Bernard Lyon 1 Univ, Lab Emergent Pathogens, Hosp Civils Lyon, Hop Edouard Herriot,CIRI,Unit Epidemiol, Lyon, France Claude Bernard Lyon 1 Univ, Lab Emergent Pathogens, Hosp Civils Lyon, Hop Edouard Herriot,CIRI,Infect Control Unit, Lyon, France Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, FranceLe-Bouar, M.论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, FranceDuru, G.论文数: 0 引用数: 0 h-index: 0机构: Claude Bernard Lyon 1 Univ, Dept Biostat, 43 Bd,11 Novembre 1918,BP 761, F-69622 Villeurbanne, France Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, FranceDalle, S.论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, FranceThomas, L.论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France Lyon 1 Univ, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Dermatol, 165 Chemin Grand Revoyet, F-69495 Pierre Benite, France
- [32] Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanomaJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (07)Pires da Silva, Ines论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia Blacktown & Westmead Hosp, Sydney, NSW, Australia Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaZakria, Danny论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN USA Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaAhmed, Tasnia论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaTrojanello, Claudia论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori IRCCS Fdn Pascale, Unit Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaDimitriou, Florentia论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaAllayous, Clara论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, AP HP, INSERM, Dermatolooncol,U976, Paris, France Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaGerard, Camille论文数: 0 引用数: 0 h-index: 0机构: CHU Vaudois, Precis Oncol Ctr, Lausanne, Switzerland Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaZimmer, Lisa论文数: 0 引用数: 0 h-index: 0机构: Univ Duisburg Essen, Univ Hosp Essen, Dept Dermatol, Essen, Germany Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaLo, Serigne论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaMichielin, Olivier论文数: 0 引用数: 0 h-index: 0机构: CHU Vaudois, Precis Oncol Ctr, Lausanne, Switzerland Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaLebbe, Celeste论文数: 0 引用数: 0 h-index: 0机构: Univ Paris Cite, Hop St Louis, AP HP, INSERM,U976,Dermatolooncol, Paris, France Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaMangana, Johanna论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaAscierto, Paolo Antonio论文数: 0 引用数: 0 h-index: 0机构: Ist Nazl Tumori IRCCS Fdn Pascale, Unit Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaJohnson, Douglas B.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN USA Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaCarlino, Matteo论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Blacktown & Westmead Hosp, Sydney, NSW, Australia Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaMenzies, Alexander论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia Royal North Shore & Mater Hosp, Sydney, NSW, Australia Univ Sydney, Melanoma Inst Australia, Sydney, NSW, AustraliaLong, Georgina论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia Royal North Shore & Mater Hosp, Sydney, NSW, Australia Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
- [33] Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanomaBMC Cancer, 18M. Amini-Adle论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 University,Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de LyonN. Khanafer论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 University,Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de LyonM. Le-Bouar论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 University,Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de LyonG. Duru论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 University,Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de LyonS. Dalle论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 University,Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de LyonL. Thomas论文数: 0 引用数: 0 h-index: 0机构: Lyon 1 University,Department of Dermatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
- [34] SDCBP modulates tumor microenvironment, tumor progression and anti-PD1 efficacy in colorectal cancerCANCER GENE THERAPY, 2024, 31 (05) : 755 - 765Yu, Jiahua论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R China Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R ChinaYu, Shijun论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R China Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R ChinaBai, Jin论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R China Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R ChinaZhu, Zhe论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Dept Colorectal Surg, Shanghai 200120, Peoples R China Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R ChinaGao, Yong论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R China Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R ChinaLi, Yandong论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R China Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai 200120, Peoples R China
- [35] Efficacy and safety of anti-PD-1 inhibitor combined with nab-paclitaxel in Chinese patients with refractory melanomaJournal of Cancer Research and Clinical Oncology, 2022, 148 : 1159 - 1169Jing-jing Li论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterJiu-hong Wang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterYa Dingv论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterDan-dan Li论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterXi-zhi Wen论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterJing-jing Zhao论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterHang Jiang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterXing Liu论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterFu-xue Huang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy CenterXiao-shi Zhang论文数: 0 引用数: 0 h-index: 0机构: Sun Yat-Sen University Cancer Center,Biotherapy Center
- [36] Treatment Options for Advanced Melanoma After Anti-PD-1 TherapyCURRENT ONCOLOGY REPORTS, 2020, 22 (04)Babacan, Nalan Akgul论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USA H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USAEroglu, Zeynep论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USA Univ S Florida, Morsani Sch Med, Dept Oncol Sci, Tampa, FL 33620 USA H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL 33612 USA
- [37] Efficacy and Safety of Iparomlimab, an Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors: A Phase 1c StudyADVANCES IN THERAPY, 2024, 41 (11) : 4153 - 4171Xiong, Jianping论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaOuyang, Weiwei论文数: 0 引用数: 0 h-index: 0机构: Guizhou Canc Hosp, Phase 1 Ward, Guiyang, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaYang, Mengxiang论文数: 0 引用数: 0 h-index: 0机构: Liaocheng Peoples Hosp, Dept Oncol, Liaocheng, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaGao, Zhenyuan论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Med Oncol, Bengbu, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaZhou, Huan论文数: 0 引用数: 0 h-index: 0机构: Bengbu Med Coll, Affiliated Hosp 1, Dept Med Oncol, Bengbu, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaLou, Hanmei论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Canc Hosp, Phase 1 Ward, Hangzhou, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaGuo, Yabing论文数: 0 引用数: 0 h-index: 0机构: Nanfang Hosp, Liver Canc Ctr, Phase 1 Clin Res Lab, Guangzhou, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaXu, Zhongyuan论文数: 0 引用数: 0 h-index: 0机构: Nanfang Hosp, Liver Canc Ctr, Phase 1 Clin Res Lab, Guangzhou, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaZheng, Ling论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ, Mengchao Hepatobiliary Hosp, Phase 1 Ward, Fuzhou, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaLiu, Ying论文数: 0 引用数: 0 h-index: 0机构: Henan Canc Hosp, Ward Digest Dis 3, Zhengzhou, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaWang, Zhongfeng论文数: 0 引用数: 0 h-index: 0机构: First Hosp Jilin Univ, Henan Canc Hosp, Changchun, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaSun, Ping论文数: 0 引用数: 0 h-index: 0机构: Yantai Yuhuangding Hosp, Dept Med Oncol, Yantai, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaNiyazi, Huerxidan论文数: 0 引用数: 0 h-index: 0机构: Xinjiang Med Univ, Affiliated Hosp 1, Phase 1 Ward, Dept Oncol, Urumqi, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaWang, Jianhua论文数: 0 引用数: 0 h-index: 0机构: Xinjiang Med Univ, Affiliated Hosp 1, Phase 1 Ward, Dept Oncol, Urumqi, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaChen, Yan论文数: 0 引用数: 0 h-index: 0机构: Qilu Pharmaceut Co Ltd, Clin Res & Dev Ctr, Jinan, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaZhang, Baihui论文数: 0 引用数: 0 h-index: 0机构: Qilu Pharmaceut Co Ltd, Clin Res & Dev Ctr, Jinan, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaLi, Lingyan论文数: 0 引用数: 0 h-index: 0机构: Qilu Pharmaceut Co Ltd, Clin Res & Dev Ctr, Jinan, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaKang, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Qilu Pharmaceut Co Ltd, Clin Res & Dev Ctr, Jinan, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R ChinaGuo, Weijian论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Med Oncol, Nanchang, Peoples R China
- [38] Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanomaANNALS OF ONCOLOGY, 2017, 28 (05) : 1130 - 1136Lee, J. H.论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Blacktown Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Univ Sydney, Westmead Inst, Translat Canc Res Ctr, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaLong, G. V.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Northern Sydney Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaBoyd, S.论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaLo, S.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaMenzies, A. M.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Northern Sydney Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaTembe, V.论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Westmead Inst, Translat Canc Res Ctr, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaGuminski, A.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Northern Sydney Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaJakrot, V.论文数: 0 引用数: 0 h-index: 0机构: Melanoma Inst Australia, Sydney, NSW, Australia Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaScolyer, R. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaMann, G. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Sydney, Westmead Inst, Translat Canc Res Ctr, Sydney, NSW, Australia Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaKefford, R. F.论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Blacktown Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Univ Sydney, Westmead Inst, Translat Canc Res Ctr, Sydney, NSW, Australia Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaCarlino, M. S.论文数: 0 引用数: 0 h-index: 0机构: Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Blacktown Hosp, Crown Princess Mary Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia Univ Sydney, Westmead Inst, Translat Canc Res Ctr, Sydney, NSW, Australia Melanoma Inst Australia, Sydney, NSW, Australia Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, AustraliaRizos, H.论文数: 0 引用数: 0 h-index: 0机构: Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia Melanoma Inst Australia, Sydney, NSW, Australia Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia
- [39] Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patientsINVESTIGATIONAL NEW DRUGS, 2017, 35 (04) : 436 - 441Heidelberger, Valentine论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceGoldwasser, Francois论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceKramkimel, Nora论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Dermatol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceJouinot, Anne论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceHuillard, Olivier论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceBoudou-Rouquette, Pascaline论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceChanal, Johan论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Dermatol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceArrondeau, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceFranck, Nathalie论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Dermatol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceAlexandre, Jerome论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceBlanchet, Benoit论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, CERTIM Grp, Dept Pharmacokinet & Pharmacochem, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceLeroy, Karen论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, CERTIM Grp, Dept Biochem & Mol Biol, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceAvril, Marie-Francoise论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Dermatol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceDupin, Nicolas论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Dermatol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, FranceAractingi, Selim论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 05, Dept Dermatol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France Univ Paris 05, Dept Med Oncol, CERTIM Grp, Cochin Port Royal Hosp,AP HP, 123 Bd Port Royal, F-75679 Paris 14, France
- [40] Complete responses to two different anti-PD1 agents in a metastatic melanoma patientJOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 496 - 499Kilickap, Saadettin论文数: 0 引用数: 0 h-index: 0机构: Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, Turkey Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, TurkeyGuven, Deniz C.论文数: 0 引用数: 0 h-index: 0机构: Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, TurkeyAktepe, Oktay H.论文数: 0 引用数: 0 h-index: 0机构: Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, TurkeyAktas, Burak Y.论文数: 0 引用数: 0 h-index: 0机构: Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, TurkeyDizdar, Omer论文数: 0 引用数: 0 h-index: 0机构: Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, Turkey Hacettepe Univ, Dept Prevent Oncol, Canc Inst, Ankara, Turkey